Health authorities in England are launching a vaccination campaign targeting young people at elevated risk of meningitis B infection. The initiative provides free doses of the MenB vaccine to approximately one million eligible individuals, with nearly 90,000 doses already administered and 135,000 additional appointments scheduled for the coming weeks.
The campaign was prompted by an outbreak in Kent that resulted in 29 confirmed or suspected cases and two deaths within weeks. The outbreak was characterized as unprecedented and explosive by health officials. First-year university students face a risk approximately seven times higher than their non-university attending peers, according to NHS England. The increased risk among this population is attributed to heightened social mixing and shared accommodation in residential settings.
Eligible recipients include 17 and 18-year-olds currently in sixth form, students under 25 entering university for the first time in autumn, and those beginning residential further education programs. International students and individuals from other UK nations studying in England are also eligible. The vaccine requires two doses administered at least 28 days apart for optimal protection. Seventeen and 18-year-olds can book through the NHS National Booking Service if registered with a GP, while other eligible students can access walk-in services at participating pharmacies across England without requiring GP registration.
Meningitis B infection can cause severe complications including meningitis, sepsis, and potentially fatal outcomes. Survivors may experience life-altering disabilities such as hearing loss, brain damage, or amputations. The vaccine does not contain live bacteria and cannot cause meningitis. Common side effects include mild fever, nausea, headache, or injection site reactions that typically resolve within one to two days. More severe adverse effects are rare.
The MenB vaccine was added to routine childhood immunizations for babies born after 1 July 2015, creating a gap in protection for older teenagers and young adults. Vaccine experts are recommending that government officials consider implementing routine vaccination for all teenagers around age 15, though individual nations retain decision-making authority on this matter.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI